Brugada syndrome: Controversies in Risk stratification and Management.
Year: 2010
Type: article
Abstract: In the 18 years since the first description of Brugada Syndrome in a small series of cardiac arrest survivors it has become evident that there is a marked spectrum in phenotype and prognosis. An internal cardiac defibrillator (ICD) is the only established therapy but is associated with significant morbidity. A number of registries have published their data, but risk stratification, particularly in asymptomatic patients, remains controversial. This article summarises the evidence to enable the clinician to make informed management decisions on an individual basis.
Source: PubMed
Authors: Lm Nunn, J Bhar-Amato, Pd Lambiase
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1607708790
